Johnson & Johnson slips after quarterly results

** Shares of Johnson & Johnson JNJ.N fall 1% to $261.51 premarket

** Co reports Q3 adj EPS of $2.59, above analysts' est of $2.54 - LSEG

** Co posts Q3 sales of $25.4 bln, above analysts' est of $25.28 bln - LSEG

** Co lifts its 2026 forecast and now expects about $101.2 bln in reported sales and adjusted EPS of $11.10 at the midpoint, compared with prior view of about $101.1 bln in reported sales and adjusted EPS of $11.04

** Analysts, on avg, expect 2026 sales of about $101.3 bln and adjusted EPS of $11.08 - LSEG data

** Among 26 brokerages, 19 rate J&J "buy" or higher and 7 rate it "hold", while the median price target is $282 - LSEG

** As of last close, JNJ up 27.4% YTD, outperforming the S&P 500 .SPX 11.7% rise